Continuous EGFR-TKI administration following radiotherapy for non-small cell lung cancer patients with isolated CNS failure-Reference-Cited by-同舟云学术

Continuous EGFR-TKI administration following radiotherapy for non-small cell lung cancer patients with isolated CNS failure

Published:2011-12 Issue:3 Volume:74 Page:457-461
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Shukuya Takehito,Takahashi Toshiaki,Naito Tateaki,Kaira Rieko,Ono Akira,Nakamura Yukiko,Tsuya Asuka,Kenmotsu Hirotsugu,Murakami Haruyasu,Harada Hideyuki,Mitsuya Koichi,Endo Masahiro,Nakasu Yoko,Takahashi Kazuhisa,Yamamoto Nobuyuki

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference12 articles.

1. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

2. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial;Mitsudomi;Lancet Oncol,2010

3. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;Maemondo;N Engl J Med,2010

4. Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib;Kosaka;Clin Cancer Res,2006

5. Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with nonsmall-cell lung cancer;Lee;Cancer,2010

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Local Therapy for Oligo-Progressive Disease in Oncogene-Addicted Non-Small-Cell Lung Cancer;Advances in Radiation Oncology;2024-07

2. Management of oligometastatic and oligoprogressive epidermal growth factor receptor mutated non-small cell lung cancer patients: state of the art of a combined approach;Exploration of Targeted Anti-tumor Therapy;2024-05-17

3. Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and Immunotherapies;Current Oncology Reports;2024-01

4. The Emerging Role of Radiotherapy in Oligoprogressive Non-Small Cell Lung Cancer;Surgical Oncology Clinics of North America;2023-07

5. EGFR-Directed Therapy in Lung Cancer;El in Molecular Onco;2023-01-05